United Kingdom
The European Centre for Disease Prevention and Control announced that clusters and outbreaks of hepatitis A virus (HAV) genotype IB with four unique but closely related HAV sequences have been reported in six European Union (EU) countries and in the United Kingdom (UK).
As of 29 September 2022, 303 cases with identical or closely related HAV strains have been identified in Austria (7), Germany (8), Hungary (161), the Netherlands (8), Slovenia (35), Sweden (8), and the UK (76). Currently, available epidemiological and microbiological data suggest that human-to-human transmission has occurred, and possibly also transmission through contaminated food.
On 15 February 2022, Hungary reported an outbreak of HAV genotype IB with the disease onset of the first case in early December 2021. To date, 161 cases (139 males, 22 females) have been confirmed with this strain in the National Hepatitis Reference Laboratory in Hungary. The weekly number of reported hepatitis A cases have been declining since June 2022. In July 2022, a foodborne outbreak was suspected with a link to a restaurant in Hungary, where 16 people fell ill with HAV IB infection. Some of the patients reported consuming cold soup made with frozen berries.
In the UK, no clear source of infection has been identified, but epidemiological investigations so far indicate possible foodborne infections in addition to person-to-person transmission.
Germany, the Netherlands, and Sweden have reported a total of 9 cases infected with strains matching the sequences of the UK strain. Investigations of these cases didn’t find any clear risk factors for infection such as a travel history or consumption of berries. Further investigations are ongoing.
If you are experiencing Hepatitis A symptoms like fever, jaundice, nausea, clay-colored stool, dark urine, malaise, abdominal discomfort, or vomiting, it is important to report it. It can help to detect and resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Source:
www.ecdc.europa.eu
